Literature DB >> 16832163

Relationship between the concentration and antiatherogenic activity of high-density lipoproteins.

Philip J Barter1, Kerry-Anne Rye.   

Abstract

PURPOSE OF REVIEW: The relationship between the concentration of high-density lipoprotein cholesterol and their protective function is addressed. RECENT
FINDINGS: Strong epidemiologic evidence indicates that the concentration of high-density lipoproteins is a powerful inverse predictor of cardiovascular risk. This is consistent with the fact that high levels of high-density lipoprotein are generally associated with an increased concentration of large high-density lipoprotein particles that are now known to be the preferred acceptors of cholesterol released from macrophages via the adenosine triphosphate-binding cassette A1 pathway. Some of the protective activity, however, of high-density lipoproteins may reflect functions of specific subpopulations or variations in the 'quality' of high-density lipoprotein particles and may be unrelated to the concentration of the total high-density lipoprotein fraction. This review summarizes the cardiovascular protective role of high-density lipoproteins and addresses how the concentration and antiatherogenic activity of high-density lipoproteins are related.
SUMMARY: Some of the protective functions of high-density lipoprotein are closely related to the simple concentration of high-density lipoproteins; others may not be related. Given the current high level of interest in therapies that raise the concentration of high-density lipoprotein, it is essential to conduct further research to identify precisely how high-density lipoproteins protect.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16832163     DOI: 10.1097/01.mol.0000236365.40969.af

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  21 in total

Review 1.  Ecto-F₁-ATPase: a moonlighting protein complex and an unexpected apoA-I receptor.

Authors:  Pierre Vantourout; Claudia Radojkovic; Laeticia Lichtenstein; Véronique Pons; Eric Champagne; Laurent O Martinez
Journal:  World J Gastroenterol       Date:  2010-12-21       Impact factor: 5.742

2.  Rosuvastatin does not affect human apolipoprotein A-I expression in genetically modified mice: a clue to the disputed effect of statins on HDL.

Authors:  Marta Marchesi; Cinzia Parolini; Silvia Caligari; Donatella Gilio; Stefano Manzini; Marco Busnelli; Paola Cinquanta; Marina Camera; Marta Brambilla; Cesare R Sirtori; Giulia Chiesa
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

3.  Congruency between biophysical data from multiple platforms and molecular dynamics simulation of the double-super helix model of nascent high-density lipoprotein.

Authors:  Valentin Gogonea; Zhiping Wu; Xavier Lee; Vitaliy Pipich; Xin-Min Li; Alexander I Ioffe; Joseph A Didonato; Stanley L Hazen
Journal:  Biochemistry       Date:  2010-08-31       Impact factor: 3.162

4.  No influence of increased intake of orange and blackcurrant juices and dietary amounts of vitamin E on paraoxonase-1 activity in patients with peripheral arterial disease.

Authors:  Christine Dalgård; Lene Christiansen; Torbjörn Jonung; Michael I Mackness; Moniek P M de Maat; Mogens Hørder
Journal:  Eur J Nutr       Date:  2007-08-21       Impact factor: 5.614

5.  In vitro simultaneous transfer of lipids to HDL in coronary artery disease and in statin treatment.

Authors:  Ana C Lo Prete; Clederson H Dina; Carolina H Azevedo; Camila G Puk; Neuza H M Lopes; Whady A Hueb; Raul Cavalcante Maranhão
Journal:  Lipids       Date:  2009-09-16       Impact factor: 1.880

6.  Association between hepatic lipase -514 C/T promoter polymorphism and myocardial infarction is modified by history of hypercholesterolemia and waist circumference.

Authors:  A Baylin; E Ruiz-Narvaez; M K Jensen; E Rimm; H Campos
Journal:  Nutr Metab Cardiovasc Dis       Date:  2009-08-19       Impact factor: 4.222

7.  Pressure perturbation calorimetry of apolipoproteins in solution and in model lipoproteins.

Authors:  Sangeeta Benjwal; Olga Gursky
Journal:  Proteins       Date:  2010-04

8.  The low-resolution structure of nHDL reconstituted with DMPC with and without cholesterol reveals a mechanism for particle expansion.

Authors:  Valentin Gogonea; Gary S Gerstenecker; Zhiping Wu; Xavier Lee; Celalettin Topbas; Matthew A Wagner; Thomas C Tallant; Jonathan D Smith; Philip Callow; Vitaliy Pipich; Hélène Malet; Guy Schoehn; Joseph A DiDonato; Stanley L Hazen
Journal:  J Lipid Res       Date:  2013-01-23       Impact factor: 5.922

9.  Dose-dependent regulation of high-density lipoprotein metabolism with rosuvastatin in the metabolic syndrome.

Authors:  Esther M M Ooi; Gerald F Watts; Paul J Nestel; Dmitri Sviridov; Anh Hoang; P Hugh R Barrett
Journal:  J Clin Endocrinol Metab       Date:  2007-11-20       Impact factor: 5.958

10.  Particulate matter and atherosclerosis: role of particle size, composition and oxidative stress.

Authors:  Jesus A Araujo; Andre E Nel
Journal:  Part Fibre Toxicol       Date:  2009-09-18       Impact factor: 9.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.